UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000016095
Receipt No. R000018408
Official scientific title of the study Factors affects ulcer healing after gastric endoscopic submucosal dissection
Date of disclosure of the study information 2015/01/01
Last modified on 2016/08/19 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Factors affects ulcer healing after gastric endoscopic submucosal dissection
Title of the study (Brief title) Factors affects ulcer healing after gastric endoscopic submucosal dissection
Region
Japan

Condition
Condition superficial gastric neoplasm
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To clarify the factor affecting ulcer healing after gastric-ESD
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes ulcer reduction rate
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1.cancers referring to the expanded criteria
2.cancers excluded by the above criteria that were treated at patient's request
3. gastric adenomas that were difficult to distinguish from cancer.
Key exclusion criteria (1) experienced delayed bleeding, (2) required additional surgery, (3) had previous surgery, (4) were lost to follow-up, (5) required steroid injection to prevent stenosis, or (6) had poor compliance with oral administration of the study drugs (> 20%).
Target sample size 300

Research contact person
Name of lead principal investigator Yohei Horikawa
Organization Hiraka General Hospital
Division name Gastroenterology
Address Maego 3-1, Yatsukuchi, Yokote city
TEL 0182-32-5121
Email horikawa_01@me.com

Public contact
Name of contact person Yohei Horikawa
Organization Hiraka General Hospital
Division name Gastroenterology
Address Maego 3-1, Yatsukuchi, Yokote city
TEL 0182-32-5121
Homepage URL
Email horikawa_01@me.com

Sponsor
Institute Hiraka General Hospital
Institute
Department

Funding Source
Organization nothing
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 01 Month 01 Day

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 12 Month 01 Day
Anticipated trial start date
2014 Year 12 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information measuring ulcer size at endoscopy on 4W/8W after ESD

Management information
Registered date
2014 Year 12 Month 31 Day
Last modified on
2016 Year 08 Month 19 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018408